https://www.pharmanow.live/latest-news/ronanrx-fda-warning-letter-glp1-compounding-misbranding-2026 2026-11-03T23:26:48+05:30 Pharma Now en 2026-11-03T00:00:00+05:30 RonanRx Receives FDA Warning Letter Over False GLP-1 Compounding Claims RonanRx https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/a9eb61ce-8b4a-40d1-b483-f9709306845a/2ccf2bed-ac8e-42d5-b6a4-4808f79150ef.png https://www.pharmanow.live/latest-news/shilpa-cdmo-50-million-peptide-manufacturing-glp1 2026-11-03T23:41:42+05:30 Pharma Now en 2026-11-03T00:00:00+05:30 Shilpa CDMO Invests $50 Million in Commercial Peptide Manufacturing Shilpa https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/a9eb61ce-8b4a-40d1-b483-f9709306845a/609586f8-f9ba-43fb-8fe4-5b68cf9cb137.png https://www.pharmanow.live/latest-news/ong-tien-usa-llc-fda-warning-letter-piroxicam-dexamethasone-2026 2026-11-03T23:29:53+05:30 Pharma Now en 2026-11-03T00:00:00+05:30 Ong Tien USA LLC Receives FDA Warning Letter After Lab Testing Confirms Hidden Pharmaceutical Ingredients Ong Tien https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/a9eb61ce-8b4a-40d1-b483-f9709306845a/641d0dc0-7a22-4a06-a459-5692ef3d833e.png https://www.pharmanow.live/latest-news/fda-warning-letter-bellas-nutri-shop-hidden-opioid-nsaid-ingredients-2026 2026-11-03T23:34:32+05:30 Pharma Now en 2026-11-03T00:00:00+05:30 FDA Issues Warning Letter to Bella's Nutri Shop After Lab Confirms Hidden Opioid and NSAID Ingredients FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/a9eb61ce-8b4a-40d1-b483-f9709306845a/98f65db0-ef6e-400f-86e4-369ad6da63ef.png https://www.pharmanow.live/latest-news/fda-warning-letter-new-york-tong-ren-tang-unapproved-drugs-2026 2026-11-03T23:30:51+05:30 Pharma Now en 2026-11-03T00:00:00+05:30 FDA Issues Warning Letter to New York Tong Ren Tang Over Three Unapproved Drug Products FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/a9eb61ce-8b4a-40d1-b483-f9709306845a/d42aac1d-8454-442c-9457-3d2d7ef00cf9.png https://www.pharmanow.live/latest-news/fda-warning-letter-new-green-nutrition-undeclared-dexamethasone-herbal-supplement 2026-11-03T23:32:14+05:30 Pharma Now en 2026-11-03T00:00:00+05:30 FDA Issues Warning Letter to New Green Nutrition After Lab Confirms Undeclared Dexamethasone in Herbal Supplement FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/a9eb61ce-8b4a-40d1-b483-f9709306845a/fa7e7ee0-bd2b-4c2d-a5fd-20a32b0d0deb.png https://www.pharmanow.live/latest-news/lupin-launches-raltegravir-600mg-tablets-us-180-day-exclusivity 2026-11-03T23:33:29+05:30 Pharma Now en 2026-11-03T00:00:00+05:30 Lupin Launches RaltegravirTablets in US Market Securing Generic Exclusivity Lupin https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/a9eb61ce-8b4a-40d1-b483-f9709306845a/534f5102-9cf7-4645-ab4a-94909b90d7eb.png https://www.pharmanow.live/latest-news/fda-warning-letter-natuzem-unapproved-drugs-mexico-2026 2026-11-03T23:41:02+05:30 Pharma Now en 2026-11-03T00:00:00+05:30 FDA Issues Warning Letter to Natuzem Over Three Unapproved Drugs Sold Online from Mexico FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/a9eb61ce-8b4a-40d1-b483-f9709306845a/d5435601-5cb9-4ee1-825d-f3ed582eca0f.png https://www.pharmanow.live/latest-news/gland-pharma-fda-approval-methylprednisolone-acetate-injectable-vials 2026-11-03T23:36:18+05:30 Pharma Now en 2026-11-03T00:00:00+05:30 Gland Pharma Gains FDA Approval for Methylprednisolone Acetate Injectable Gland https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/5fb50c3b-2cd2-42ae-8071-d9d2e3fbe905/71bc0de3-afba-49e5-b965-e2b734196088.png https://www.pharmanow.live/latest-news/ideaya-biosciences-nda-submission-darovasertib-metastatic-uveal-melanoma 2026-11-03T23:37:53+05:30 Pharma Now en 2026-11-03T00:00:00+05:30 IDEAYA Biosciences Submits NDA for Darovasertib Combination in Metastatic Uveal Melanoma IDEAYA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/5fb50c3b-2cd2-42ae-8071-d9d2e3fbe905/a44c86cd-049f-48ef-b95b-c07825f0057e.png https://www.pharmanow.live/latest-news/teva-discontinues-phase-2-emrusolmin-trial-futility-analysis-msa 2026-11-03T23:40:20+05:30 Pharma Now en 2026-11-03T00:00:00+05:30 Teva Discontinues Phase 2 Emrusolmin Trial After Futility Analysis in MSA Program Teva https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/5fb50c3b-2cd2-42ae-8071-d9d2e3fbe905/d91f2a67-d2e9-41c5-ba79-cd04f1dd227e.png https://www.pharmanow.live/latest-news/akums-acquires-oriflame-india-manufacturing-assets-rs-56-crore-cdmo-expansion 2026-11-03T23:39:21+05:30 Pharma Now en 2026-11-03T00:00:00+05:30 Akums Acquires Oriflame India Manufacturing Assets in Rs 56 Crore CDMO Expansion Akums https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/bbd4e467-603c-48e9-8f72-f42417462e2d/df5bb40f-9027-4f7a-84a4-af315caf1953.png https://www.pharmanow.live/latest-news/oryzon-gains-spanish-authorization-vivaldi-phase-ib-aml-cetlam 2026-11-03T23:25:30+05:30 Pharma Now en 2026-11-03T00:00:00+05:30 Oryzon Gains Spanish Authorization for VIVALDI Phase Ib AML Study Oryzon https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/bbd4e467-603c-48e9-8f72-f42417462e2d/dd227d01-08bf-4608-801e-0c11f48ddbad.png https://www.pharmanow.live/latest-news/karyopharm-signs-merger-ayrmid-chapter-11-selinexor 2026-11-03T12:01:49+05:30 Pharma Now en 2026-11-02T00:00:00+05:30 Karyopharm Signs Merger Agreement with Ayrmid Karyopharm https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/karyopharm-ayrmid-chapter-11-merger-selinexor-supply-202620261103120139.webp https://www.pharmanow.live/latest-news/dr-reddys-tentative-usfda-approval-generic-lenacapavir-pepfar-120-nations 2026-11-03T11:53:31+05:30 Pharma Now en 2026-11-02T00:00:00+05:30 Dr. Reddy's Wins Tentative FDA Approval for Generic Lenacapavir Dr. Reddy's https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/dr-reddys-generic-lenacapavir-tentative-fda-approval-hiv-prevention-202620261103115201.webp https://www.pharmanow.live/latest-news/fda-final-potency-assurance-guidance-cell-gene-therapy-2026 2026-11-03T11:36:40+05:30 Pharma Now en 2026-11-02T00:00:00+05:30 FDA Finalizes CGT Potency Guidance for Lifecycle-Wide Quality FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fda-final-potency-assurance-guidance-cell-gene-therapy-manufacturing-202620261103113555.webp https://www.pharmanow.live/latest-news/tonix-pharmaceuticals-appoints-george-lederman-evp-strategy-transformation 2026-11-03T11:30:28+05:30 Pharma Now en 2026-11-02T00:00:00+05:30 Tonix Appoints George Lederman as EVP, Strategy & Transformation Tonix https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/tonix-pharmaceuticals-george-lederman-evp-strategy-transformation-appointment-202620261103112938.webp https://www.pharmanow.live/latest-news/spektus-pharma-gebro-global-deal-actraflex-pain-drug 2026-11-03T11:02:26+05:30 Pharma Now en 2026-11-02T00:00:00+05:30 Spektus Signs Global ActraFlex Commercialisation Deal with GEBRO Spektus https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/spektus-gebro-actraflex-global-commercialisation-partnership-202620261103110213.webp https://www.pharmanow.live/latest-news/glenmark-pharmaceuticals-appoints-namita-shah-senior-vice-president-global-portfolio 2026-11-03T10:50:43+05:30 Pharma Now en 2026-11-02T00:00:00+05:30 Glenmark Elevates Namita Shah to Senior VP, Global Portfolio Glenmark https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/glenmark-namita-shah-senior-vice-president-global-portfolio-appointment-202620261103104919.webp